香港六合彩中特网

Professor Anette Schrag (香港六合彩中特网 Institute of Neurology) co-authored the study, which analysed UK health data across 10 years and is the first ever report of long-term healthcare costs of Parkinson鈥檚.

The research, co-led with PHMR, found that over 10 years of follow-up post diagnosis, for patients with Parkinson鈥檚, the cost of healthcare - including hospital visits and medications - averaged 拢5,022 per year. This was compared to 拢2,001 in yearly medical costs in a control group that was matched by age, sex and other conditions.

But the researchers say this is an underestimate of the total costs of care, as it did not include out-of-pocket expenditures by patients, privately insured spending, caregiving costs, or social costs such as lost earnings or costs to social services. They estimate the total costs of Parkinson鈥檚 are at least 拢25,000 per patient per year.

For the study, published in Movement Disorders, the research team drew from two linked UK databases (primary care and hospital data) to identify all use of medical resources for 7,271 people with Parkinson鈥檚 and 7,060 matched controls, over a 10-year period starting at first diagnosis.

This approach incorporated all medical costs, including Parkinson鈥檚-related problems such as falls or infections that may not have been directly attributed to Parkinson鈥檚 in medical records, combined costs to primary and hospital care, and studied expenditure over a prolonged period of time.

The researchers estimated the total health care costs attributable to Parkinson鈥檚 by subtracting the control group鈥檚 average costs from those in the Parkinson鈥檚 group. This difference was found to be 拢2,471 in the first year post-diagnosis, rising to 拢4,004 in the tenth year.

The greatest difference in expenses arose in primary care and hospital stays as inpatients, which respectively cost 1.9 times and 2.5 times more for Parkinson鈥檚 patients compared to controls.

While only a relatively small expense, those with Parkinson鈥檚 were also more than twice as likely to visit A&E in a given year.

The overall annual cost of 拢5,022 in Parkinson鈥檚 in this study is comparable to a 2014 by Alzheimer鈥檚 Society, which estimated the yearly health care costs of dementia at 拢5,285 per year.[1]

As these costs gradually increased over time and covered much more than just direct treatment costs for Parkinson鈥檚, the researchers say their findings highlight the importance of finding treatments to delay of slow progression of Parkinson鈥檚.

Professor Schrag said, 鈥淥ur study highlights that Parkinson鈥檚 is very costly not only to patients and their families but also to the NHS and to society, and expenses include much more than just direct treatments, which emphasises the value of finding new treatments to prevent or delay Parkinson鈥檚.鈥�

Links

• Weir et al. 鈥楽hort- and long-term cost and utilization of health care resources in Parkinson鈥檚 disease in the UK. Movement Disorders. First published:聽30 March 2018
• Professor Anette Schrag鈥檚 IRIS profile

References

[1] Alzheimer鈥檚 Society. Dementia UK Update. 2014.